Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Inventiva (IVA) has a market cap of $0.33 billion USD. According to our data, Inventiva is ranked No.6437 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.33 B |
190.07%
|
| Dec 31, 2024 | $0.11 B |
-52.61%
|
| Dec 29, 2023 | $0.24 B |
1.26%
|
| Dec 30, 2022 | $0.23 B |
-67.35%
|
| Dec 31, 2021 | $0.72 B |
-5.79%
|
| Dec 31, 2020 | $0.76 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Madrigal Pharmaceuticals
MDGL
|
$7.09 B |
-0.000 M
|
USA
|
 Genfit
GNFT
|
$0.18 B |
0.000 M
|
France
|
 Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
Israel
|
 Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
USA
|
 Akero Therapeutics
AKRO
|
$3.03 B |
0.000 M
|
USA
|
 89bio
ETNB
|
$0.88 B |
-0.000 M
|
USA
|
 Hepion Pharmaceuticals
HEPA
|
$3.84 M |
3.463 M
|
USA
|
 Terns Pharmaceuticals
TERN
|
$0.21 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
| Market Cap | = | IVA Stock Price | * | IVA Shares Outstanding |
| = | $3.40 | * | 95.54 M | |
| = | $0.33 B |